The Effect of Topical Bevacizumab on Corneal Neovascularization

Nursing and Health Professions

• Cornea Neovascularization 100%
• Patient 66%
• Bevacizumab 66%
• Adverse Event 33%
• Evaluation Study 33%
• Agents Acting on the Eye 33%
• Topical Drug Administration 16%
• Visual Acuity 16%
• Procedures 16%
• Skin Defect 16%
• Slit Lamp Microscopy 16%
• Erosion 16%

Medicine and Dentistry

• Corneal Neovascularization 100%
• Bevacizumab 66%
• Adverse Event 33%
• Agents Acting on the Eye 33%
• Evaluation Study 33%
• Therapeutic Procedure 33%
• Visual Acuity 16%
• Topical Drug Administration 16%
• Skin Defect 16%
• Slit Lamp Microscopy 16%
• Tonometry 16%
• Erosion 16%